Pub Date : 2022-09-27DOI: 10.35479/ijretina.2022.vol005.iss002.196
S. Widyawati, H. Putri, V. D. Oktarina
Introduction: To highlight the therapeutic dilemma in managing complications in high myopia patient with complicated cataract after vitrectomy who previously had refractive surgery. Case Report: A 37-years old man, presented with half the right eye view was being blocked by a black curtain for one week before admission. He had a history of high myopia on both eyes and underwent phakic intraocular lens (PIOL) implantation 12 years ago. Presenting visual acuity (VA) of the right eye was hand motion (HM). Retinal detachment (RD) on inferior side, and clear lens with anterior chamber (AC) PIOL were found in the examination. Patient underwent vitrectomy, endolaser, and silicone oil in the next four days. A sudden severe pain with red-eye was found one month after surgery, intraocular pressure (IOP) was increased to 43 mmHg, the lens was white opaque with lens material seen in AC. Discussion: The diagnosis of traumatic cataract and lens-particle-induced glaucoma was made. Lens mass evacuation surgery was performed after initial antiglaucoma medication. Posterior capsule rupture was found intraoperatively with only a small amount of lens mass remaining. Visual acuity result after the second surgery is still dissatisfied with the presence of rubeosis iridis, with the possibility of retinal re-detachment was still present. Conclusion: High myopia still poses a greater risk of ocular complications. It can be corrected by refractive surgery, with expensive cost and it will not prevent potential future ocular problems. Repeated assessment before and after refractive surgery procedure is mandatory in order to prevent sight-threatening complications of high myopia which might lead to other blinding complications.
{"title":"MANAGEMENT CASE OF POST PHAKIC INTRAOCULAR LENS IMPLANT IN HIGH MYOPIA WITH COMPLICATED CATARACT AFTER VITRECTOMY: POST SURGERY CHALLENGES","authors":"S. Widyawati, H. Putri, V. D. Oktarina","doi":"10.35479/ijretina.2022.vol005.iss002.196","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss002.196","url":null,"abstract":"Introduction: To highlight the therapeutic dilemma in managing complications in high myopia patient with complicated cataract after vitrectomy who previously had refractive surgery. \u0000Case Report: A 37-years old man, presented with half the right eye view was being blocked by a black curtain for one week before admission. He had a history of high myopia on both eyes and underwent phakic intraocular lens (PIOL) implantation 12 years ago. Presenting visual acuity (VA) of the right eye was hand motion (HM). Retinal detachment (RD) on inferior side, and clear lens with anterior chamber (AC) PIOL were found in the examination. Patient underwent vitrectomy, endolaser, and silicone oil in the next four days. A sudden severe pain with red-eye was found one month after surgery, intraocular pressure (IOP) was increased to 43 mmHg, the lens was white opaque with lens material seen in AC. \u0000Discussion: The diagnosis of traumatic cataract and lens-particle-induced glaucoma was made. Lens mass evacuation surgery was performed after initial antiglaucoma medication. Posterior capsule rupture was found intraoperatively with only a small amount of lens mass remaining. Visual acuity result after the second surgery is still dissatisfied with the presence of rubeosis iridis, with the possibility of retinal re-detachment was still present. \u0000Conclusion: High myopia still poses a greater risk of ocular complications. It can be corrected by refractive surgery, with expensive cost and it will not prevent potential future ocular problems. Repeated assessment before and after refractive surgery procedure is mandatory in order to prevent sight-threatening complications of high myopia which might lead to other blinding complications.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"147 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78587118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-27DOI: 10.35479/ijretina.2022.vol005.iss002.194
Yurike Mandrasari, Wino Vrieda Vierlia, Andhika Yudistira, N. Dewi
Introduction: Von Hippel-Lindau (VHL) syndrome is a disease characterized by the formation of tumors or cysts in many different parts of the body caused by germline. The prevalence of this autosomal dominant condition is very rare. Understanding of clinical manifestasion and diagnostic criteria is needed. Case Report: Female, 22-year-old was reffered from orthopaedic department suffered from blurred and misalignment of the left eye since 3 months ago . Based on indirect funduscopy examination, we found disc swelling with exudative retinal detachment on her left eye and orange-reddish retinal mass concluded as Retinal Capillary Hemangioblastoma (RCH) with tortuosity and dilatation of blood vessel on her right eye. The MRI showed multiple masses in cervical to lumbar vertebrae and multiple cyst on pancreatic gland. Discussion: This patient had 1 ocular RCH, multiple spinal tumor and multiple pancreatic cysts with no confirmed family history, therefore almost fulfilling the diagnostic criteria of VHL. To further confirm the diagnosis, it was necessary to find other common comorbids of VHL such as gene testing of VHL heterozygous germline mutation. Interdisciplinary approach consists of not only diagnostic and treatment plans from one speciality department, but also the ones from other related divisions and departments. Conclusion: Screening and interdiciplinary approach in managing Von Hippel-Lindau syndrome are required to be performed promptly.
{"title":"DIAGNOSING VON HIPPEL LINDAU DISEASE BY RETINAL CAPILLARY HAEMANGIOBLASTOMAS","authors":"Yurike Mandrasari, Wino Vrieda Vierlia, Andhika Yudistira, N. Dewi","doi":"10.35479/ijretina.2022.vol005.iss002.194","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss002.194","url":null,"abstract":"Introduction: Von Hippel-Lindau (VHL) syndrome is a disease characterized by the formation of tumors or cysts in many different parts of the body caused by germline. The prevalence of this autosomal dominant condition is very rare. Understanding of clinical manifestasion and diagnostic criteria is needed. \u0000Case Report: Female, 22-year-old was reffered from orthopaedic department suffered from blurred and misalignment of the left eye since 3 months ago . Based on indirect funduscopy examination, we found disc swelling with exudative retinal detachment on her left eye and orange-reddish retinal mass concluded as Retinal Capillary Hemangioblastoma (RCH) with tortuosity and dilatation of blood vessel on her right eye. The MRI showed multiple masses in cervical to lumbar vertebrae and multiple cyst on pancreatic gland. \u0000Discussion: This patient had 1 ocular RCH, multiple spinal tumor and multiple pancreatic cysts with no confirmed family history, therefore almost fulfilling the diagnostic criteria of VHL. To further confirm the diagnosis, it was necessary to find other common comorbids of VHL such as gene testing of VHL heterozygous germline mutation. Interdisciplinary approach consists of not only diagnostic and treatment plans from one speciality department, but also the ones from other related divisions and departments. \u0000Conclusion: Screening and interdiciplinary approach in managing Von Hippel-Lindau syndrome are required to be performed promptly.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"195 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79815179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-26DOI: 10.35479/ijretina.2022.vol005.iss002.187
Ika Citra Susanti, S. Nusanti, M. Sidik, A. Kekalih
Introduction: Multifocal electroretinography (ERG) is an examination which measures retinal electrical activity as a response to lighting stimulus and allows simultaneous recording in many topographic locations. Various electrodes have been developed to balance examination accuracy and also patients’ comfort. The objective of this study is to establish normal values of multifocal ERG and to compare the values and the comfort level using Jet, Dencott and DTL electrode in Indonesian Adult. Methods: Through convenient sampling 49 normal Indonesian subjects between 19 and 49 years old were selected. Multifocal ERG amplitudes and implicit time values were measured according to recommendation by the ISCEV. Evaluation consisted of N1 and P1 wave in ring 1 to 5. after the examination, all subjects filled in a questionnaire about comfort level, adopted from the visual analog scale. Result: We observed a statistically significant difference in multifocal ERG normal values between electrode with higher wave amplitudes and longer implicit time in Jet and Dencott electrodes compared to DTL electrodes. Jet and DTL electrodes are more comfortable than Dencott electrodes for Indonesian adults in multifocal ERG. Conclusion: DTL electrodes give the lowest wave amplitude and the shortest implicit time and are the most comfortable electrode compared to Jet and Dencott electrodes, in multifocal ERG in Indonesian adults.
{"title":"Comparison of Amplitude and Implicit Time Between Jet Electrode, Dencott Electrode and Dawson-Trick-Litzkow Electrode in Multifocal Electroretinography Examination in Adult","authors":"Ika Citra Susanti, S. Nusanti, M. Sidik, A. Kekalih","doi":"10.35479/ijretina.2022.vol005.iss002.187","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss002.187","url":null,"abstract":"Introduction: Multifocal electroretinography (ERG) is an examination which measures retinal electrical activity as a response to lighting stimulus and allows simultaneous recording in many topographic locations. Various electrodes have been developed to balance examination accuracy and also patients’ comfort. The objective of this study is to establish normal values of multifocal ERG and to compare the values and the comfort level using Jet, Dencott and DTL electrode in Indonesian Adult. \u0000Methods: Through convenient sampling 49 normal Indonesian subjects between 19 and 49 years old were selected. Multifocal ERG amplitudes and implicit time values were measured according to recommendation by the ISCEV. Evaluation consisted of N1 and P1 wave in ring 1 to 5. after the examination, all subjects filled in a questionnaire about comfort level, adopted from the visual analog scale. \u0000Result: We observed a statistically significant difference in multifocal ERG normal values between electrode with higher wave amplitudes and longer implicit time in Jet and Dencott electrodes compared to DTL electrodes. Jet and DTL electrodes are more comfortable than Dencott electrodes for Indonesian adults in multifocal ERG. \u0000Conclusion: DTL electrodes give the lowest wave amplitude and the shortest implicit time and are the most comfortable electrode compared to Jet and Dencott electrodes, in multifocal ERG in Indonesian adults.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85685393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-26DOI: 10.35479/ijretina.2022.vol005.iss002.203
S. Supanji, A. N. Agni
Introduction: Diabetic macular edema (DME) is a debilitating complication of the diabetic eye. Vascular Endothelial Growth Factor (VEGF) was found to be responsible for this disease entity, and anti-VEGF remains the main treatment of DME. Inflammatory processes occur in diabetic eye, with some researchers postulates the role of them in the making of DME. This study’s objective is to search for anti-VEGF alternative using Non-Steroid Anti-Inflammatory Drugs (NSAID), ketorolac tromethamine. Methods: We conducted a double blind, randomized clinical trial in DME patients using intravitreal injection of bevacizumab and ketorolac. Central macular thickness (CMT) was assessed pre-treatment and one-month post-treatment. Best Corrected Visual Acuity (BCVA) and Intraocular Pressure (IOP) were also assessed. Wilcoxon tests were performed to evaluate changes in CMT, visual acuity, and IOP. Result: We enrolled 50 treatment-naïve DME patients from March 2020 to March 2021. Twenty-five patients were allocated for each group. There is a statistically significant difference in CMT at one-month follow-up between the two groups (p:0.001) and a markedly reduced CMT between the groups (p:0.001), with the reduction higher in bevacizumab group. BCVA changes significantly in bevacizumab group (p:0.01), but there is no statistically significant difference between the two groups (p:0.07). There’s a marked difference of IOP in 1 hour after injection in both groups, with higher transient IOP elevation in ketorolac group (p:0.02), but there is no marked difference in one-month follow-up (p:>0.05). The perceived pain right after intravitreal injection is not different between bevacizumab and ketorolac group. Conclusion: Intravitreal injection of ketorolac found to be inferior compared to bevacizumab in reducing CMT of DME. Meanwhile, there’s no differences in visual acuity, intraocular pressure (one-month follow-up) and pain after injection between two groups.
简介:糖尿病性黄斑水肿(DME)是糖尿病眼的一种衰弱性并发症。血管内皮生长因子(VEGF)被发现与这种疾病实体有关，抗VEGF仍然是DME的主要治疗方法。炎症过程发生在糖尿病眼，一些研究人员推测它们在二甲醚制造中的作用。本研究的目的是寻找非甾体抗炎药(NSAID)，酮咯酸tromethamine的抗vegf替代品。方法:我们在双盲随机临床试验中对二甲醚患者进行玻璃体内注射贝伐单抗和酮咯酸。分别在治疗前和治疗后1个月评估黄斑中央厚度(CMT)。同时评估最佳矫正视力(BCVA)和眼压(IOP)。采用Wilcoxon试验评估CMT、视力和IOP的变化。结果:我们从2020年3月至2021年3月招募了50例treatment-naïve DME患者。每组25名患者。随访1个月后，两组间CMT差异有统计学意义(p:0.001)，两组间CMT显著降低(p:0.001)，贝伐单抗组降低幅度更高。贝伐单抗组BCVA变化显著(p:0.01)，但两组间差异无统计学意义(p:0.07)。两组患者注射后1 h IOP差异有统计学意义，酮洛酸组瞬时IOP升高较高(p:0.02)， 1个月随访无统计学意义(p:>0.05)。贝伐单抗组和酮咯酸组在玻璃体内注射后即刻感知疼痛无差异。结论:与贝伐单抗相比，玻璃体内注射酮咯酸降低二甲醚CMT的效果较差。同时，两组患者的视力、眼压(随访1个月)、注射后疼痛均无差异。
{"title":"CENTRAL MACULAR THICKNESS REDUCTION AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB COMPARED TO INTRAVITREAL KETOROLAC IN NAIVE DIABETIC MACULAR EDEMA","authors":"S. Supanji, A. N. Agni","doi":"10.35479/ijretina.2022.vol005.iss002.203","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss002.203","url":null,"abstract":"Introduction: Diabetic macular edema (DME) is a debilitating complication of the diabetic eye. Vascular Endothelial Growth Factor (VEGF) was found to be responsible for this disease entity, and anti-VEGF remains the main treatment of DME. Inflammatory processes occur in diabetic eye, with some researchers postulates the role of them in the making of DME. This study’s objective is to search for anti-VEGF alternative using Non-Steroid Anti-Inflammatory Drugs (NSAID), ketorolac tromethamine. \u0000Methods: We conducted a double blind, randomized clinical trial in DME patients using intravitreal injection of bevacizumab and ketorolac. Central macular thickness (CMT) was assessed pre-treatment and one-month post-treatment. Best Corrected Visual Acuity (BCVA) and Intraocular Pressure (IOP) were also assessed. Wilcoxon tests were performed to evaluate changes in CMT, visual acuity, and IOP. \u0000Result: We enrolled 50 treatment-naïve DME patients from March 2020 to March 2021. Twenty-five patients were allocated for each group. There is a statistically significant difference in CMT at one-month follow-up between the two groups (p:0.001) and a markedly reduced CMT between the groups (p:0.001), with the reduction higher in bevacizumab group. BCVA changes significantly in bevacizumab group (p:0.01), but there is no statistically significant difference between the two groups (p:0.07). There’s a marked difference of IOP in 1 hour after injection in both groups, with higher transient IOP elevation in ketorolac group (p:0.02), but there is no marked difference in one-month follow-up (p:>0.05). The perceived pain right after intravitreal injection is not different between bevacizumab and ketorolac group. \u0000Conclusion: Intravitreal injection of ketorolac found to be inferior compared to bevacizumab in reducing CMT of DME. Meanwhile, there’s no differences in visual acuity, intraocular pressure (one-month follow-up) and pain after injection between two groups.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85706933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-26DOI: 10.35479/ijretina.2022.vol005.iss002.201
Yunneke Renna Xaverina, Ovi Sofia
Introduction: To describe the clinical manifestations and CD4 count characteristics of patients with cytomegalovirus (CMV) retinitis. Methods: This is a retrospective study of patients diagnosed with CMV retinitis at the Ophthalmology Outpatient Clinic at Dr. Saiful Anwar General Hospital, Malang, between January 2016 to December 2019. The patients’ characteristics and clinical data including gender, age, visual acuity, slit lamp biomicroscopy, indirect ophthalmoscope, and laboratory findings were collected from medical records. Result: Twenty-one eyes from thirteen patients with CMV retinitis were enrolled. The mean age was 30.9 ± 7.12 years, with 54% of them male. Bilateral lesions were observed in 62% of the patients, and the mean visual acuity during the initial visit was 1.50 ±1.07 log MAR. All patients presented with the classic form of CMV retinitis. Mean CD4 count when commencing treatment was 62.23 ±11.82 cells/µL with 77% below 50 cells/µL. Patients with CD4 count < 50 cells/µL mostly presented with posterior uveitis, bilateral lesion, and visual acuity ≤1.00 logMAR. Ten patients were given oral valganciclovir and antiretroviral therapy. Retinal detachment condition was noted at seven eyes. Candidiasis was the most presenting opportunistic infection. Conclusion: Cytomegalovirus retinitis was found in patients infected with AIDS with low CD4 counts. In this study, patients with CD4 counts of below 50 cells/µL tend to have more severe clinical presentations.
{"title":"CLINICAL MANIFESTATIONS AND CD4 COUNT CHARACTERISTICS OF PATIENTS WITH CYTOMEGALOVIRUS (CMV) RETINITIS","authors":"Yunneke Renna Xaverina, Ovi Sofia","doi":"10.35479/ijretina.2022.vol005.iss002.201","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss002.201","url":null,"abstract":"Introduction: To describe the clinical manifestations and CD4 count characteristics of patients with cytomegalovirus (CMV) retinitis. \u0000Methods: This is a retrospective study of patients diagnosed with CMV retinitis at the Ophthalmology Outpatient Clinic at Dr. Saiful Anwar General Hospital, Malang, between January 2016 to December 2019. The patients’ characteristics and clinical data including gender, age, visual acuity, slit lamp biomicroscopy, indirect ophthalmoscope, and laboratory findings were collected from medical records. \u0000Result: Twenty-one eyes from thirteen patients with CMV retinitis were enrolled. The mean age was 30.9 ± 7.12 years, with 54% of them male. Bilateral lesions were observed in 62% of the patients, and the mean visual acuity during the initial visit was 1.50 ±1.07 log MAR. All patients presented with the classic form of CMV retinitis. Mean CD4 count when commencing treatment was 62.23 ±11.82 cells/µL with 77% below 50 cells/µL. Patients with CD4 count < 50 cells/µL mostly presented with posterior uveitis, bilateral lesion, and visual acuity ≤1.00 logMAR. Ten patients were given oral valganciclovir and antiretroviral therapy. Retinal detachment condition was noted at seven eyes. Candidiasis was the most presenting opportunistic infection. \u0000Conclusion: Cytomegalovirus retinitis was found in patients infected with AIDS with low CD4 counts. In this study, patients with CD4 counts of below 50 cells/µL tend to have more severe clinical presentations.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88473313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-22DOI: 10.35479/ijretina.2022.vol005.iss002.199
Lucky Fitrada, Nina Ratnaningsih, Erwin Iskandar
Background: Diabetic retinopathy (DR) is a common and major complication of diabetes mellitus (DM), and is the leading cause of preventable blindness in adults of productive age after cataracts. The global prevalence of DR is 34.6% , consisting of proliferative diabetic retinopathy (7.0%), diabetic macular edema (6.8%), and visual threatening diabetic retinopathy (VTDR) (10.2%.) The risk factors for VTDR are age, duration of diabetes, glycemic control, hypertension, obesity, HbAIC levels, and dyslipidemia. In addition, impaired sleep quality is also indicated to be connected with the incidence of VTDR. Objective: To compare the incidence of VTDR between patients with and without impaired sleep quality. Methods: This was a cross-sectional comparative analytic observational study involving 178 type 2 diabetes mellitus patients with DR at the National Eye Center of Cicendo Eye Hospital who met the inclusion criteria. Subject characteristic data were taken from medical records and sleep quality data were collected through a structured interview using the Indonesian version of the Shorten Pittsburgh Sleep Quality Index (PSQI) questionnaire. Subjects were distributed into poor and good sleep quality groups. The presence of VTDR was then assessed. The differences were then analyzed statistically using chi-square test with a p value of 0.05 considered statistically significant.Results: Results showed that 66.2% and 71.1% of patients in the poor and good quality sleep group suffered from VTDR, respectively (p> 0.05). Conclusion: There is no difference in VTDR incidence between patients in productive age with type 2 DM between those with and without impaired sleep quality.
{"title":"A DIFFERENCE IN INCIDENCE OF VISUAL THREATENING DIABETIC RETINOPATHY BETWEEN PATIENTS WITH AND WITHOUT IMPAIRED SLEEP QUALITY","authors":"Lucky Fitrada, Nina Ratnaningsih, Erwin Iskandar","doi":"10.35479/ijretina.2022.vol005.iss002.199","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss002.199","url":null,"abstract":"Background: Diabetic retinopathy (DR) is a common and major complication of diabetes mellitus (DM), and is the leading cause of preventable blindness in adults of productive age after cataracts. The global prevalence of DR is 34.6% , consisting of proliferative diabetic retinopathy (7.0%), diabetic macular edema (6.8%), and visual threatening diabetic retinopathy (VTDR) (10.2%.) The risk factors for VTDR are age, duration of diabetes, glycemic control, hypertension, obesity, HbAIC levels, and dyslipidemia. In addition, impaired sleep quality is also indicated to be connected with the incidence of VTDR. \u0000Objective: To compare the incidence of VTDR between patients with and without impaired sleep quality. \u0000Methods: This was a cross-sectional comparative analytic observational study involving 178 type 2 diabetes mellitus patients with DR at the National Eye Center of Cicendo Eye Hospital who met the inclusion criteria. Subject characteristic data were taken from medical records and sleep quality data were collected through a structured interview using the Indonesian version of the Shorten Pittsburgh Sleep Quality Index (PSQI) questionnaire. Subjects were distributed into poor and good sleep quality groups. The presence of VTDR was then assessed. The differences were then analyzed statistically using chi-square test with a p value of 0.05 considered statistically significant.Results: Results showed that 66.2% and 71.1% of patients in the poor and good quality sleep group suffered from VTDR, respectively (p> 0.05). \u0000Conclusion: There is no difference in VTDR incidence between patients in productive age with type 2 DM between those with and without impaired sleep quality. \u0000 ","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"123 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72440686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-23DOI: 10.35479/ijretina.2022.vol005.iss001.148
Tyastuti Dwi, Diah Pantjawati, Semara Budiyasa, C. Hartono
Introduction: The purpose of this study is to identify the pattern and distribution of vitreoretinal (VR) diseases in Bali Mandara Eye Hospital Methods: A retrospective descriptive study was conducted for this study. We reviewed all medical records of new patient diagnosed with VR diseases, from 1 January to 31 December 2019. We recorded and measured demography, history of systemic and eye disease, symptoms and onset, ophthalmic examinations, diagnostic investigations, final diagnoses, therapies, and the completion of the visit. Results: Out of 2118 total visits, we found 1191 new cases with VR diagnosis. The male to female ratio was 1.3:1. We found a group of 46-65 years is represented in 678 cases (56.9%). Type 2 diabetes mellitus was the most commonly found as a systemic disease (15.5%), followed by the combination of diabetes and hypertension (14%) and hypertension alone (12.9%). History of previous cataract surgery was found in 174 cases (14.6%). Out of 1191 patients, 553 patients (46.4%) were blind. The most common diagnosis was diabetic retinopathy (19.7%), followed by rhegmatogenous retinal detachment (10.8%), and vitreous opacity (9.9%). Diabetic retinopathy affected both eyes in 302 cases (89.6%), while rhegmatogenous retinal detachment and vitreous opacity commonly affected one eye in 177 cases (95%) and 123 cases (73%), respectively. Proliferative diabetic retinopathy was found in 171 cases (50.7%). Conclusions: Diabetic retinopathy and rhegmatogenous retinal detachment were the most two common diagnoses. The proliferative type was slightly common than Non-Proliferative Diabetic Retinopathy. As diabetes and hypertension were the most systemic conditions we found, a collaboration with another department is needed to create a strategic screening system and early detection. An evaluation related to rhegmatogenous retinal detachment is needed to decrease the number of cases.
{"title":"VITREORETINAL DISEASES IN OUTPATIENT DEPARTMENT OF BALI MANDARA EYE HOSPITAL IN 2019","authors":"Tyastuti Dwi, Diah Pantjawati, Semara Budiyasa, C. Hartono","doi":"10.35479/ijretina.2022.vol005.iss001.148","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss001.148","url":null,"abstract":"Introduction: The purpose of this study is to identify the pattern and distribution of vitreoretinal (VR) diseases in Bali Mandara Eye Hospital \u0000Methods: A retrospective descriptive study was conducted for this study. We reviewed all medical records of new patient diagnosed with VR diseases, from 1 January to 31 December 2019. We recorded and measured demography, history of systemic and eye disease, symptoms and onset, ophthalmic examinations, diagnostic investigations, final diagnoses, therapies, and the completion of the visit. \u0000Results: Out of 2118 total visits, we found 1191 new cases with VR diagnosis. The male to female ratio was 1.3:1. We found a group of 46-65 years is represented in 678 cases (56.9%). Type 2 diabetes mellitus was the most commonly found as a systemic disease (15.5%), followed by the combination of diabetes and hypertension (14%) and hypertension alone (12.9%). History of previous cataract surgery was found in 174 cases (14.6%). Out of 1191 patients, 553 patients (46.4%) were blind. The most common diagnosis was diabetic retinopathy (19.7%), followed by rhegmatogenous retinal detachment (10.8%), and vitreous opacity (9.9%). Diabetic retinopathy affected both eyes in 302 cases (89.6%), while rhegmatogenous retinal detachment and vitreous opacity commonly affected one eye in 177 cases (95%) and 123 cases (73%), respectively. Proliferative diabetic retinopathy was found in 171 cases (50.7%). \u0000Conclusions: Diabetic retinopathy and rhegmatogenous retinal detachment were the most two common diagnoses. The proliferative type was slightly common than Non-Proliferative Diabetic Retinopathy. As diabetes and hypertension were the most systemic conditions we found, a collaboration with another department is needed to create a strategic screening system and early detection. An evaluation related to rhegmatogenous retinal detachment is needed to decrease the number of cases.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86224009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-22DOI: 10.35479/ijretina.2022.vol005.iss001.190
Rofa Husnul Khuluqi, N. Dewi, Susanto Nugroho, Lely Retno Wulandari
Introduction: To present the clinical findings of Autoimmune hemolytic anemia (AIHA) Retinopathy and its rapid resolutions following treatment with steroid. Case report: A 14-year-old female patient presented with decreased vision in the left eye. There was history of AIHA. Visual acuity was 1/60 in LE and 6/6 in RE. There was conjunctival pallor, and the other anterior segment were unremarkable. Fundus examination of left eye revealed flame shaped and dot blot hemorrhage, roth’s spots, optic disc swelling, venous turtuosity, and elevated macula. There were afferent pupil defect, red green deficiency, and contrast sensitivity decline. Hematological evaluation revealed anemia. A MRI Head and Orbital examination were unremarkable. Discussion: This patient was assessed with LE Anemic retinopathy due to AIHA. The patient’s visual acuity improved as the retinopathy resolved after 1 month of oral steroid therapy. Conclusion: Anemia may play a role in the occurrence of retinopathy. The diagnosis of retinopathy can be made by linking ophthalmic fndings with positive serological test. Accurate comprehensive examination can establish the systemic diagnosis, and control of systemic parameters will improve retinopathy, reverse vision loss, and avoid permanent blindness
{"title":"REMARKABLE RESULT TOWARDS RETINOPATHY ASSOCIATED AUTOIMMUNE HEMOLYTIC ANEMIA","authors":"Rofa Husnul Khuluqi, N. Dewi, Susanto Nugroho, Lely Retno Wulandari","doi":"10.35479/ijretina.2022.vol005.iss001.190","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss001.190","url":null,"abstract":"Introduction: To present the clinical findings of Autoimmune hemolytic anemia (AIHA) Retinopathy and its rapid resolutions following treatment with steroid. \u0000Case report: A 14-year-old female patient presented with decreased vision in the left eye. There was history of AIHA. Visual acuity was 1/60 in LE and 6/6 in RE. There was conjunctival pallor, and the other anterior segment were unremarkable. Fundus examination of left eye revealed flame shaped and dot blot hemorrhage, roth’s spots, optic disc swelling, venous turtuosity, and elevated macula. There were afferent pupil defect, red green deficiency, and contrast sensitivity decline. Hematological evaluation revealed anemia. A MRI Head and Orbital examination were unremarkable. \u0000Discussion: This patient was assessed with LE Anemic retinopathy due to AIHA. The patient’s visual acuity improved as the retinopathy resolved after 1 month of oral steroid therapy. \u0000Conclusion: Anemia may play a role in the occurrence of retinopathy. The diagnosis of retinopathy can be made by linking ophthalmic fndings with positive serological test. Accurate comprehensive examination can establish the systemic diagnosis, and control of systemic parameters will improve retinopathy, reverse vision loss, and avoid permanent blindness","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89076157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-22DOI: 10.35479/ijretina.2022.vol005.iss001.172
Aldiana Halim, Syumarti Syumarti, Mayang Rini, Nina Ratnaningsih, Erwin Iskandar, I. Sovani, Rova Virgana, Muhammad Rinaldi Dahlan
Introduction: Determine the prevalence and associated factors of diabetic retinopathy (DR) among people with type 2 diabetes. Design: Cross-sectional study Methods: We obtained data of people with type 2 diabetes retrospectively from a community-based DR screening database in Greater Bandung, Indonesia. We encoded the two fields mydriatic 45-degree fundus images to estimate prevalence. The associated factors analysis used multivariate logistic regression. Results: We screened a total of 4,251 people with type 2 diabetes from January 2016 to December 2019. The overall age-standardised prevalence of any DR was 30.7% (95% CI: 28.7%-32.8%) and vision-threatening DR 7.6% (95% CI: 6.5%-9.0%). The following factors were associated with a higher prevalence of any DR: ages 50+ (OR:1.37; 95% CI:1.05-1.77), duration of diabetes five to ten years (OR:1.38; 95% CI:1.11-1.71) and more than ten years (OR:1.40; 95% CI:1.13-1.73), and postprandial blood glucose 200 mg/dl and higher (OR:1.27; 95% CI:1.03-1.52). The following factors were associated with a higher prevalence of vision-threatening DR: duration of diabetes five to ten years (OR:2.01; 95% CI:1.39-2.91) and more than ten years (OR:1.86; 95% CI:1.28-2.71), postprandial blood glucose 200 mg/dl or higher (OR:1.52; 95% CI:1.05-2.21) and systolic blood pressure 180 mmHg or higher (OR:2.67; 95% CI:1.16-6.17). Conclusion: Diabetic retinopathy is prevalent among people with type 2 diabetes. People with diabetes should regulate their blood glucose and blood pressure to prevent retinopathy related vision loss.
{"title":"Prevalence and Associated Factors of Diabetic Retinopathy in People with Type 2 Diabetes Attending Community Based Diabetic Retinopathy Screening in Greater Bandung, Indonesia","authors":"Aldiana Halim, Syumarti Syumarti, Mayang Rini, Nina Ratnaningsih, Erwin Iskandar, I. Sovani, Rova Virgana, Muhammad Rinaldi Dahlan","doi":"10.35479/ijretina.2022.vol005.iss001.172","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss001.172","url":null,"abstract":"Introduction: Determine the prevalence and associated factors of diabetic retinopathy (DR) among people with type 2 diabetes. \u0000Design: Cross-sectional study \u0000Methods: We obtained data of people with type 2 diabetes retrospectively from a community-based DR screening database in Greater Bandung, Indonesia. We encoded the two fields mydriatic 45-degree fundus images to estimate prevalence. The associated factors analysis used multivariate logistic regression. \u0000Results: We screened a total of 4,251 people with type 2 diabetes from January 2016 to December 2019. The overall age-standardised prevalence of any DR was 30.7% (95% CI: 28.7%-32.8%) and vision-threatening DR 7.6% (95% CI: 6.5%-9.0%). The following factors were associated with a higher prevalence of any DR: ages 50+ (OR:1.37; 95% CI:1.05-1.77), duration of diabetes five to ten years (OR:1.38; 95% CI:1.11-1.71) and more than ten years (OR:1.40; 95% CI:1.13-1.73), and postprandial blood glucose 200 mg/dl and higher (OR:1.27; 95% CI:1.03-1.52). The following factors were associated with a higher prevalence of vision-threatening DR: duration of diabetes five to ten years (OR:2.01; 95% CI:1.39-2.91) and more than ten years (OR:1.86; 95% CI:1.28-2.71), postprandial blood glucose 200 mg/dl or higher (OR:1.52; 95% CI:1.05-2.21) and systolic blood pressure 180 mmHg or higher (OR:2.67; 95% CI:1.16-6.17). \u0000Conclusion: Diabetic retinopathy is prevalent among people with type 2 diabetes. People with diabetes should regulate their blood glucose and blood pressure to prevent retinopathy related vision loss.","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"121 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89941081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-22DOI: 10.35479/ijretina.2022.vol005.iss001.173
Vikas Sharma, Ankuj Tinna, V. Ambiya, Ashutosh Kumar Singh, R. Waghray
Introduction: Retinal arterio-venous malformations (AVMs) are rare, congenital, high-flow congenital developmental vascular anomalies without intervening capillary bed also known as racemose angioma, They are unilateral, nonhereditary lesions located anywhere in retina and may involve optic nerve. Case report: A 55 year old male was found to have abnormal congenital arterio-venous malformation over optic nerve head in his left eye, as an incidental clinical finding. He had reported for his routine fundus examination due to diabetes. He had no other relevant systemic findings. Further follow up was advised to see the progression of the lesion and structural damage to optic nerve. Discussion: The typical clinical picture, fluorescein angiogram findings, normal MRI brain and orbits, and normal base line blood investigations all points in favour of a congenital arterio-venous malformation. Conclusion: Arterio- venous malformations of Optic nerve head are very rare to find as compared to retinal malformations. This is the first such case report from India.
{"title":"CONGENITAL ARTERIO-VENOUS MALFORMATION OF OPTIC NERVE HEAD- A RARE CASE","authors":"Vikas Sharma, Ankuj Tinna, V. Ambiya, Ashutosh Kumar Singh, R. Waghray","doi":"10.35479/ijretina.2022.vol005.iss001.173","DOIUrl":"https://doi.org/10.35479/ijretina.2022.vol005.iss001.173","url":null,"abstract":"Introduction: Retinal arterio-venous malformations (AVMs) are rare, congenital, high-flow congenital developmental vascular anomalies without intervening capillary bed also known as racemose angioma, They are unilateral, nonhereditary lesions located anywhere in retina and may involve optic nerve. \u0000Case report: A 55 year old male was found to have abnormal congenital arterio-venous malformation over optic nerve head in his left eye, as an incidental clinical finding. He had reported for his routine fundus examination due to diabetes. He had no other relevant systemic findings. Further follow up was advised to see the progression of the lesion and structural damage to optic nerve. \u0000Discussion: The typical clinical picture, fluorescein angiogram findings, normal MRI brain and orbits, and normal base line blood investigations all points in favour of a congenital arterio-venous malformation. \u0000Conclusion: Arterio- venous malformations of Optic nerve head are very rare to find as compared to retinal malformations. This is the first such case report from India. \u0000 ","PeriodicalId":33128,"journal":{"name":"IJRETINA International Journal of Retina","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89840444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：